AndytheMKDon3 Jun 2020 08:53
Hi Andy
i couldn't agree more, i thought we were a lot further down the road than this and we had least been in discussion or were in talks or something, this does read as though we have not even started, what are we paying the NEDs for if we are not actually in talks or moving towards them at this stage, i thought they were brought on board to ensure clinical governance in the due diligence phase of any negotiation, this does smell a bit wrong now and i feel the share price will suffer as a result, i really do hope i am wrong.
Are we waving goodbye to the back of the bus??